NCT07467629 2026-03-12QLS5212 for Participants With Advanced Solid TumorsQilu Pharmaceutical Co., Ltd.Phase 1 Not yet recruiting100 enrolled
NCT07441174 2026-02-27IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid TumorsInxMed (Shanghai) Co., Ltd.Phase 1/2 Recruiting92 enrolled